Document Classification

Section Type: RESULTS

Text: Combination therapy showed superior treatment effects compared with monotherapy during the first 24 weeks as documented by changes in CD4 + cell counts (increase of 0. 08 x 10 (9) / L vs 0. 02 x 10 (9) / L ; P <. 001), ICDp24 (-88 % vs -49 % ; P =. 04), cellular viremia (-1. 27 vs -0. 20 log10 median tissue-culture infected dose [TCID50] per 10 (6) peripheral blood mononuclear cells ; P =. 001), and viral load measured by HIV-1 RNA polymerase chain reaction using a Roche method (-1. 33 vs -0. 57 log10 copies/mL ; P =. 001) or an immune-capture method (-0. 6 vs -0. 14 log10 copies/mL ; P =. 008).